Made byBobr AI

Network Biology of Protein Lipidation & Therapeutic Insights

Explore myristoylation, palmitoylation, and prenylation mechanisms. Learn how protein lipidation impacts cellular signaling and drug discovery targets.

#protein-lipidation#biochemistry#cell-signaling#systems-biology#pharmacology#molecular-biology#proteomics

Network Biology of Protein Lipidation

From Definitions to Systems-Level Applications

Graduate Seminar Series: Cellular Signaling & Integromics

Made byBobr AI

Defining the Lipid-Modified Proteome

Definition: Covalent attachment of lipid moieties to specific amino acid residues, altering hydrophobicity and membrane affinity.
Key Functions: Membrane anchoring, subcellular trafficking, protein stability, and mediating Protein-Protein Interactions (PPIs).
Timing: Can be co-translational (e.g., N-myristoylation) or post-translational (e.g., S-palmitoylation).
Made byBobr AI

Taxonomy of Protein Lipidation

N-Myristoylation

Lipid: Myristate (C14:0)
Target: N-term Glycine
Nature: Irreversible, Co-translational.

S-Palmitoylation

Lipid: Palmitate (C16:0)
Target: Internal Cysteine
Nature: Reversible, Post-translational.

Prenylation

Lipid: Farnesyl (C15) / Geranylgeranyl (C20)
Target: C-term Cysteine (CaaX box)
Nature: Irreversible, Post-translational.

GPI Anchors

Lipid: Phosphatidylinositol glycan
Target: C-terminus
Nature: Complex, Luminal/Extracellular facing.

Made byBobr AI

Focus: The Dynamic Palmitoylation Cycle

Unlike other lipidations, S-palmitoylation is reversible utilizing a thioester bond.

Writers: ZDHHC family (PATs) - Zinc finger domain containing enzymes.

Erasers: APTs / ABHDs (Thioesterases).

This cycle creates a rapid regulatory switch analogous to phosphorylation.
Made byBobr AI

Network Biology: Enzyme-Substrate Architectures

Protein lipidation enzymes (e.g., the 23 mammalian ZDHHCs) exhibit complex substrate specificities, creating dense interaction networks.

Hubs & Spokes: ZDHHC enzymes act as 'hubs' modulating the localization of hundreds of 'spoke' substrates.
Redundancy: Overlap in enzyme specificity provides system robustness.
Made byBobr AI

Mechanism of Prenylation: The CaaX Box

Signal Motif: The CaaX motif at the C-terminus.
C = Cysteine
a = Aliphatic AA
X = Determinant (Ser/Met -> Farnesyl; Leu -> Geranylgeranyl).
Sequential Processing:
1. Cytosolic prenylation (FTase/GGTase)
2. ER-associated cleavage (-aaX removal)
3. Carboxyl-methylation (ICMT)
4. Result: Hydrophobic C-terminus anchors to membranes.
Made byBobr AI

Membrane Compartmentalization & Trafficking

Chart
Kinetic Trapping: Lipid modifications act as 'zip codes'.
Golgi: Primary site of PAT activity.
PM: Destination for signaling.
Acylation Cycle: Allows proteins to 'hop' between internal membranes and the PM based on their lipidation state.
Made byBobr AI

Case Study: The Ras Superfamily

  • H-Ras / N-Ras: undergo both Farnesylation and Palmitoylation.
  • K-Ras: undergoes Farnesylation and has a Polybasic electrostatic domain (no palmitoylation).
  • Significance: 30% of human cancers are driven by Ras mutations.
  • Network Impact: Lipid anchors dictate Ras isoform-specific signaling nanodomains on the PM.
Made byBobr AI

Multi-Omics: Integrating the Lipidome

Chart
Modern network biology relies on high-throughput identification.

Integration Strategy:
1. Proteomics: Identify modified cysteines.
2. Transcriptomics: Correlate with ZDHHC expression profiles.
3. Interactomics: Map dynamic PPIs dependent on lipidation.
Made byBobr AI

Applications: Drug Discovery Targets

FTase Inhibitors (FTIs):
Initially developed for Ras-driven cancers. Revival in Progeria treatment (Lonafarnib).
NMT Inhibitors:
Targeting N-myristoyltransferase in fungal infections and malaria (Plasmodium NMT).
ZDHHC Specific Inhibitors:
Emerging field. Targeting specific PATs relevant to neurological disorders (e.g., ZDHHC9 in epilepsy) and cancer.
Made byBobr AI

Experimental Tools: Probing the Lipidome

Acyl-Biotin Exchange (ABE) / APE:
Chemical substitution of thioester-linked lipids with biotin, followed by streptavidin pull-down.
Pros: No metabolic labeling needed.
Cons: False positives possible.
Bioorthogonal 'Click' Chemistry:
Metabolic labeling with fatty acid analogs (e.g., 17-ODYA, Alk-16). Reaction with fluorescent or biotin tags.
Pros: Live cell tracking, high specificity.
Cons: Requires time for incorporation.
Made byBobr AI

Summary & Future Directions

  • Protein lipidation is a critical determinant of network topology, governing subcellular localization and signaling duration.
  • Enzyme-substrate specificity (ZDHHCs, FTase) remains a complex 'many-to-many' network problem requiring systems biology approaches.
  • Future Frontier: Deciphering the regulating logic of the 'Palmitoylation Code' and developing isoform-specific inhibitors for clinical applications.
Made byBobr AI
Bobr AI

DESIGNER-MADE
PRESENTATION,
GENERATED FROM
YOUR PROMPT

Create your own professional slide deck with real images, data charts, and unique design in under a minute.

Generate For Free

Network Biology of Protein Lipidation & Therapeutic Insights

Explore myristoylation, palmitoylation, and prenylation mechanisms. Learn how protein lipidation impacts cellular signaling and drug discovery targets.

Network Biology of Protein Lipidation

From Definitions to Systems-Level Applications

Graduate Seminar Series: Cellular Signaling & Integromics

Defining the Lipid-Modified Proteome

<b>Definition:</b> Covalent attachment of lipid moieties to specific amino acid residues, altering hydrophobicity and membrane affinity.

<b>Key Functions:</b> Membrane anchoring, subcellular trafficking, protein stability, and mediating Protein-Protein Interactions (PPIs).

<b>Timing:</b> Can be co-translational (e.g., N-myristoylation) or post-translational (e.g., S-palmitoylation).

Taxonomy of Protein Lipidation

<h3 style='margin:0; color:#E74C3C;'>N-Myristoylation</h3><p><b>Lipid:</b> Myristate (C14:0)<br><b>Target:</b> N-term Glycine<br><b>Nature:</b> Irreversible, Co-translational.</p>

<h3 style='margin:0; color:#27AE60;'>S-Palmitoylation</h3><p><b>Lipid:</b> Palmitate (C16:0)<br><b>Target:</b> Internal Cysteine<br><b>Nature:</b> Reversible, Post-translational.</p>

<h3 style='margin:0; color:#8E44AD;'>Prenylation</h3><p><b>Lipid:</b> Farnesyl (C15) / Geranylgeranyl (C20)<br><b>Target:</b> C-term Cysteine (CaaX box)<br><b>Nature:</b> Irreversible, Post-translational.</p>

<h3 style='margin:0; color:#F39C12;'>GPI Anchors</h3><p><b>Lipid:</b> Phosphatidylinositol glycan<br><b>Target:</b> C-terminus<br><b>Nature:</b> Complex, Luminal/Extracellular facing.</p>

Focus: The Dynamic Palmitoylation Cycle

Unlike other lipidations, S-palmitoylation is <b>reversible</b> utilizing a thioester bond.<br><br><b>Writers:</b> ZDHHC family (PATs) - Zinc finger domain containing enzymes.<br><br><b>Erasers:</b> APTs / ABHDs (Thioesterases).<br><br>This cycle creates a rapid regulatory switch analogous to phosphorylation.

Network Biology: Enzyme-Substrate Architectures

Protein lipidation enzymes (e.g., the 23 mammalian ZDHHCs) exhibit complex substrate specificities, creating dense interaction networks.

<b>Hubs & Spokes:</b> ZDHHC enzymes act as 'hubs' modulating the localization of hundreds of 'spoke' substrates.<br><b>Redundancy:</b> Overlap in enzyme specificity provides system robustness.

Mechanism of Prenylation: The CaaX Box

<b>Signal Motif:</b> The CaaX motif at the C-terminus.<br>C = Cysteine<br>a = Aliphatic AA<br>X = Determinant (Ser/Met -> Farnesyl; Leu -> Geranylgeranyl).

<b>Sequential Processing:</b><br>1. Cytosolic prenylation (FTase/GGTase)<br>2. ER-associated cleavage (-aaX removal)<br>3. Carboxyl-methylation (ICMT)<br>4. Result: Hydrophobic C-terminus anchors to membranes.

Membrane Compartmentalization & Trafficking

Relative distribution of lipidated proteins across cellular compartments.

<b>Kinetic Trapping:</b> Lipid modifications act as 'zip codes'.<br>• <i>Golgi:</i> Primary site of PAT activity.<br>• <i>PM:</i> Destination for signaling.<br>• <i>Acylation Cycle:</i> Allows proteins to 'hop' between internal membranes and the PM based on their lipidation state.

Case Study: The Ras Superfamily

<ul><li><b>H-Ras / N-Ras:</b> undergo both Farnesylation and Palmitoylation.</li><li><b>K-Ras:</b> undergoes Farnesylation and has a Polybasic electrostatic domain (no palmitoylation).</li><li><b>Significance:</b> 30% of human cancers are driven by Ras mutations.</li><li><b>Network Impact:</b> Lipid anchors dictate Ras isoform-specific signaling nanodomains on the PM.</li></ul>

Multi-Omics: Integrating the Lipidome

Evolution of S-Palmitoylome Detection

Modern network biology relies on high-throughput identification.<br><br><b>Integration Strategy:</b><br>1. <b>Proteomics:</b> Identify modified cysteines.<br>2. <b>Transcriptomics:</b> Correlate with ZDHHC expression profiles.<br>3. <b>Interactomics:</b> Map dynamic PPIs dependent on lipidation.

Applications: Drug Discovery Targets

<b>FTase Inhibitors (FTIs):</b><br>Initially developed for Ras-driven cancers. Revival in Progeria treatment (Lonafarnib).

<b>NMT Inhibitors:</b><br>Targeting N-myristoyltransferase in fungal infections and malaria (Plasmodium NMT).

<b>ZDHHC Specific Inhibitors:</b><br>Emerging field. Targeting specific PATs relevant to neurological disorders (e.g., ZDHHC9 in epilepsy) and cancer.

Experimental Tools: Probing the Lipidome

<b>Acyl-Biotin Exchange (ABE) / APE:</b><br>Chemical substitution of thioester-linked lipids with biotin, followed by streptavidin pull-down. <br><i>Pros:</i> No metabolic labeling needed.<br><i>Cons:</i> False positives possible.

<b>Bioorthogonal 'Click' Chemistry:</b><br>Metabolic labeling with fatty acid analogs (e.g., 17-ODYA, Alk-16). Reaction with fluorescent or biotin tags.<br><i>Pros:</i> Live cell tracking, high specificity.<br><i>Cons:</i> Requires time for incorporation.

Summary & Future Directions

Protein lipidation is a critical determinant of network topology, governing subcellular localization and signaling duration.

Enzyme-substrate specificity (ZDHHCs, FTase) remains a complex 'many-to-many' network problem requiring systems biology approaches.

<b>Future Frontier:</b> Deciphering the regulating logic of the 'Palmitoylation Code' and developing isoform-specific inhibitors for clinical applications.

  • protein-lipidation
  • biochemistry
  • cell-signaling
  • systems-biology
  • pharmacology
  • molecular-biology
  • proteomics